People with kidney disease are disproportionately affected by atherosclerosis for unclear
reasons. Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived …

Sudden cardiac death (SCD) is a sudden, unexpected death that is caused by the loss of
heart function. While SCD affects many patients suffering from coronary artery diseases …

Background Previous studies have demonstrated that a soluble urokinase‐type
plasminogen activator receptor (suPAR) plays an essential function in leukocytes and …

This review summarizes the published literature referring to the use and validity of the
biomarker soluble urokinase plasminogen activator receptor (suPAR) when used for the …

Despite guideline-based therapy, patients with coronary artery disease (CAD) are at widely
variable risk for cardiovascular events. This variability demands a more individualized risk …

Purpose The Emory Cardiovascular Biobank (EmCAB) is an ongoing prospective registry of
patients undergoing cardiac catheterisation, which was established to identify novel factors …

Background Literature suggests a bidirectional association between advanced hepatic
fibrosis (AHF) and coronary artery disease (CAD). We evaluated the association of AHF with …

Background Accurate assessment of inflammatory status of patients during acute coronary
syndrome (ACS) has become of great importance in their risk classification and in the …

Results At baseline, the median suPAR was 4462 pg/ml, mean measured GFR was 46
ml/min per 1.73 m 2, and median 24-hour urine protein-to-creatinine ratio was 80 mg/g. After …

Background Multiple biomarkers have been independently and additively associated with
major adverse cardiovascular events in patients with coronary artery disease. We …